Kantify Pipeline Announcement
Today, we are very excited to disclose our pipeline on the Kantify website, showcasing our focus on Cancer, Rare Cancers, Rare Neuromuscular Disorders, Neurology, and Ion Channels.
Sapian™, our advanced AI platform, gas made significant progress in tackling some of the toughest challenges in drug discovery and AI driven drug discovery.
Sapian in a nutshell
Kantify's drug discovery technology Sapian has already identified promising drugs, novel therapeutic targets, and first-in-class modulators. Sapian’s ability to "generalize" sets it apart. It can discover molecules even in areas where no known modulators exist and identify new targets for diseases where drug discovery urgently needs to advance. These capabilities demonstrate the growing potential of AI to revolutionize drug discovery in "hard to drug" indications and targets.
What our pipeline page contains
On our pipeline page, you’ll find:
-
Diseases We Target: Learn about the indications we’re working on, from cancers to rare disorders.
-
Our Partners: Meet the collaborators helping us drive innovation.
-
First-in-Class Modulators: Discover the unique molecules Sapian has identified.
For Drug Discovery professionals: Our pipeline page also includes success rates for small molecule and target discovery. Please get in touch to learn more about our different assets and enquire about possible collaborations.
Get in touch to discuss possible collaborations.